baber/WOPTO huggingface dataset:
Patent AU-2019202930-A1 (AU)
Title: Control System and Method for Tapered Structure Construction
Inventor: TAKATA ROSALIND K
IPC: B21C37/12
Filed: 2019-04-26
Abstract: A control system for forming a tapered structure includes a sensor providing feedback for a machine for forming a tapered structure including at least three rolls having at least one bend roll and at least two guide rolls. The guide rolls may include rollette banks having a plurality of rollettes. The machine may also include an adjustment mechanism to position at least one of the rolls, where a diameter of the tapered structure being formed is controlled by relative positions of the rolls. The machine may also include a joining element to join edges of a stock of material together as it is rolled through the rolls to form the tapered structure. The control system may also include a controller to receive feedback from the sensor and to send a control signal based on the feedback to the adjustment mechanism for positioning at least one of the rolls. WO 2015/148756 PCT/US2015/022648 C) (D 0
Patent AU-2019204239-A1 (AU)
Title: Forced induction system
Inventor: KAMIYA YOSHIAKI
IPC: F02D41/00
Filed: 2019-06-17
Abstract: When the forced induction mode is a single forced induction mode (YES at S100), and when it is determined that there is a request for switching to a twin forced induction mode (YES at S102), the control device executes a process including the step 5 of executing an approach-run operation (S104), the step of executing a control for equalizing the VN opening degree (S106), and the step of switching to the twin forced induction mode (S110) when it is determined that a second boost pressure has reached a first boost pressure (YES at S108).
Patent AU-2019219004-A1 (AU)
Title: Treatment of ophthalmologic diseases
Inventor: OSBORNE AARON
IPC: A61P27/02
Filed: 2019-02-05
Abstract: The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.
Patent AU-2019220407-A1 (AU)
Title: Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect
Inventor: DAVIES GARETH CHARLES GLYNDWR
IPC: A61P19/00
Filed: 2019-02-14
Abstract: The present invention relates to methods for the treatment of a bone fracture or bone defect. The invention discloses the effective use of an anti-gremlin-1 antibody to accelerate the healing and bridging of bone tissue in segmental gap defects; and demonstrates that inhibitors of gremlin-1 activity may provide improved therapies for treating or preventing fracture non-union.
Patent AU-2019250233-A1 (AU)
Title: Tibial implant having an anatomic stem
Inventor: LANDON RYAN L
IPC: A61F2/32
Filed: 2019-10-18
Abstract: Abstract Disclosed herein are systems, methods, and devices for providing a tibial implant including an anatomic stem that provides a close interface between the implant and surrounding bone. The stem varies in size, cross-sectional shape, or orientation from a proximal portion of the stem to the tip of the stem. The variation of the stem accommodates the variation of tibial anatomy into which the implant component is implanted. The stem provides resistance against rotation of the implant and reduces stress shielding effects by transmitting forces into surrounding bone. In certain implementations, the interface between the stem and bone is supplemented by fin extensions that extend outward from the stem and increase the contact between the implant and the surrounding bone structure. WO 2013/142332 PCT/US2013/032115 120-130 LATERAL 11 MEDIAL '123 LATERAL MEDIAL ."110
Patent AU-2019262340-A1 (AU)
Title: Mutual authentication of a user-controllable device or system containing sensitive or confidential data
Inventor: BACCA NICOLAS
IPC: G06F21/44
Filed: 2019-04-30
Abstract: Method of mutual authentication of a controllable electronic device (DE) and of its user (USER) able to control it so that it procures him a service (DS), the device (DE) containing sensitive or confidential data (DA) and being arranged so as to - in an operational phase (OP) including a preliminary step of authentication of the user (UAP) -, execute an operation (SO) so as to procure the service (DS), comprising, furthermore, a prior phase of authentication of the device (SDAP), in which the authenticity of the device (DE) is verified, so that if on completion of the prior phase of authentication of the device (SDAP), the device (DE) is confirmed to be authentic, the user (USER) can execute the operational phase (OP), whilst if the device (DE) is not confirmed to be authentic, the user (USER) can prevent the execution of the operational phase (OP).
Patent AU-2019284047-A1 (AU)
Title: Electronic devices
Inventor: FRYATT CHRISTOPHER
IPC: G06F13/38
Filed: 2019-12-23
Abstract: An electronic device (10) comprises a housing (11) defining an internal volume, and an internal surface, an electronic circuit unit (12) including a controller, and a conductive element (15) located solely in the internal volume of the housing (11) on the internal surface 5 thereof, and electrically connected to the controller of the electronic circuit unit (12). 10--- 16a 16b
Patent AU-2019285416-A1 (AU)
Title: Bariatric wheelchair
Inventor: RONCIN JEAN-MICHEL
IPC: A61G5/14
Filed: 2019-06-04
Abstract: There is described a bariatric wheelchair (1), in particular a manual wheelchair, comprising a wheelchair chassis (30), a seating area (10) provided on the wheelchair chassis (30), a backrest (20) supported onto the wheelchair chassis (30), as well as front wheels (45) and rear wheels (40) provided on the wheelchair chassis (30) to allow wheeling of the wheelchair (1). The backrest (20) exhibits a lower backrest portion supported onto the wheelchair chassis (30), next to the seating area (10), the seating area (10) and lower backrest portion having a first width (W1) that is selected to accommodate a wheelchair user's nominal hips width (WH) ranging between 500 millimeters and 800 millimeters. The backrest (20) further exhibits an upper backrest portion, in the vicinity of the wheelchair user's shoulders, having a second width (W2) that is smaller than the first width (W1), which second width (W2) is selected to liberate space for movement of the wheelchair user's arms and shoulders and so as not to exceed a wheelchair user's nominal shoulder articulation width (WS) ranging between 400 millimeters and 600 millimeters.
Patent AU-2019294154-A1 (AU)
Title: Mouthfeel enhancing composition
Inventor: TIWARI RASHMI
IPC: A23L27/30
Filed: 2019-06-19
Abstract: This disclosure provides novel compositions comprising a compound of Formula (I). These compositions are useful for improving mouthfeel properties of non-nutritive sweeteners, such as steviol glycosides and blends thereof, in food and beverages containing the same.
Patent AU-2019296517-A1 (AU)
Title: A toaster
Inventor: THIE JOHNSON
IPC: A47J37/08
Filed: 2019-06-28
Abstract: There is disclosed herein a toaster (10) including: a housing (12); a pair of opposing food guards (24a, 24b) located within the housing (12) and defining a toasting cavity (25a, 25b) for receiving foodstuff to be toasted; a pair of heating elements (28) located within the housing (12), each heating element (28) being located on a respective side of the pair of food guards (24a, 24b), wherein each food guard (24a, 24b) is spaced from the corresponding heating element (28) by a clearance (81); and wherein each food guard (24a, 24b) has an upwardly-extending portion (75c, 75d) that extends upwardly to a portion (75a, 75b) that extends transversely from the upwardly-extending portion so as to extend above the corresponding heating element (28), the transversely-extending portion (75a, 75b) of each food guard (24a, 24b) projecting away from the opposing food guard (24a, 24b).
Patent AU-2019313443-A1 (AU)
Title: Oligonucleotides comprising a phosphorotrithioate internucleoside linkage
Inventor: BLEICHER KONRAD
IPC: C07H21/00
Filed: 2019-07-29
Abstract: The present invention relates to an oligonucleotide comprising at least one phosphorotrithioate intemucleoside linkage of formula (I) as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicament.
Patent AU-2019315857-A1 (AU)
Title: Aqueous fluid filter assembly with aeration mitigation
Inventor: KUIECK BRYAN
IPC: F02M37/22
Filed: 2019-07-30
Abstract: An aqueous fluid filter assembly with aeration mitigation includes a cap, a bowl engaging the cap and defining a filter volume, and a filter element disposed in the filter volume. The filter element is sealed against an interior of the cap and an interior of the bowl to provide an unfiltered volume and a filtered volume. An inlet is in fluid communication with the unfiltered volume and an outlet is in fluid communication with the filtered volume via a pickup section. The pickup section has a pick-up section inlet extending into the filtered volume and an air-metering orifice, wherein the air-metering orifice has a diameter less than 30% of the diameter of the pick-up section inlet and the pick-up section inlet is located below the air-metering orifice.
Patent AU-2019401944-A1 (AU)
Title: Quick tracer injection for monitoring osmosis membrane integrity
Inventor: YOON SEONG-HOON
IPC: B01D65/10
Filed: 2019-12-06
Abstract: A fluorometric monitoring technique can be used to rapidly evaluate the efficiency of an osmosis membrane. In some examples, the technique includes injecting a bolus of fluorescent tracer into a feed stream. The tracer may be introduced for a period of time less than what is required for the tracer to reach an equilibrium concentration in the permeate stream. The feed stream and the permeate stream may be fluorometrically analyzed to determine a flow rate-independent cumulative-time concentration of the fluorescent tracer in the both streams. The efficiency of the osmosis membrane can then be determined based on these flow rate-independent cumulative-time concentrations.
Patent AU-2019411438-A1 (AU)
Title: Insecticidal formulation for vector and pest control with increased contact efficacy
Inventor: VERMEER ARNOLDUS
IPC: A01N25/10
Filed: 2019-12-10
Abstract: The present invention relates to insecticidal formulations for vector and pest control with increased contact efficacy, more particularly to insecticidal active ingredient - matrix particles and insecticidal compositions comprising such insecticidal active ingredient - matrix particles, as well as to methods and uses of such insecticidal formulations.
Patent AU-2019419502-A1 (AU)
Title: Systems and methods for treatment of obstructive sleep apnea
Inventor: CHRISTOPHERSON MARK
IPC: A61B18/02
Filed: 2019-12-31
Abstract: Methods, devices, and systems employ cryolysis of oropharyngeal adipose tissues to selectively remove fat cells from the tissues causing obstructive sleep apnea. In various embodiments, a chilled liquid - e.g., a liquid or air - is applied to the target tissue at a temperature and for a duration sufficient to cause cryolysis.
Patent AU-2019471214-A1 (AU)
Title: Power bank with detectable receptacles
Inventor: EASTER KENNETH NATHANIEL
IPC: H01R13/66
Filed: 2019-10-25
Abstract: In a particular implementation, an apparatus configured for power delivery includes a port configured to changeably receive interface modules of a plurality of interface modules. The interface modules of the plurality of interface modules include receptacles configured to interface with corresponding connector configurations. The port is configured to electrically couple a receptacle of an interface module received by the port to a power supply component of the power delivery apparatus coupled to the port. The apparatus also includes a detector configured to determine a receptacle type of the receptacle of the interface module received by the port. One or more characteristics of the power supply component are controlled based on the determined receptacle type to correspond to a power signal appropriate to the receptacle type of the interface module received by the port.
Patent WO-2020142810-A1 (WO)
Inventor: SUZUKI KIYONORI
IPC: C22C33/04
Filed: 2020-01-09
Abstract: An alloy having formula (Fe 1-x Co x ) 100-y-z-a B y Cu z M a , in which x = 0.1 - 0.4, y = 10 – 16, z = 0 – 1, α = 0 – 8, and M = Nb, Mo, Ta, W, Ni, or Sn, wherein the alloy has crystalline grains with an average size of 30 nm or less.
Patent AU-2020200475-A1 (AU)
Title: Anchorless intragastric device for treating obesity
Inventor: SHARMA VIRENDER K
IPC: A61F5/00
Filed: 2020-01-23
Abstract: A intragastric device that contains a compressible free-floating structure and a sleeve attached thereto is provided. The device is considered to be anchorless as the sleeve is not physically attached to any portion of the GI tract. The device is 5 configurable between a compressed pre-deployment configuration and an expanded post-deployment configuration. The free-floating device may be composed of a shape memory material such a nitinol. In some embodiments , the free-floating structure is space occupying and non-porous. The sleeve may be attached to the free-floating structure, such as with sutures and/or glue. In some embodiments, a stent may be 0 inserted at the proximal end of the sleeve. A second free-floating structure may be connected to the free-floating structure such that there is an upper structure and a lower structure. In some embodiments, the gastrointestinal device is used to deliver prebiotic and/or probiotic therapy to a patient. 12053666_1 (GHMatters) P109917.AU.1 WO 2017/189682 PCT/US2017/029571
Patent AU-2020203286-A1 (AU)
Title: Transporter with adjustable center of gravity
Inventor: SJARIF RIDWAN
IPC: B62D24/04
Filed: 2020-05-20
Abstract: Page 1 of 14 
Transporter with adjustable centre of gravity 
Abstract 
Transporter with multi wheeler which travelled on the ground through dip and 
turn its body move side to side from midline axis of transporter, changing its 
centre of gravity to offset centrifugal force on turning and changing camber of 
the ground in safety and maintaining its stability 
Description 
The present application claims priority from Australia. provisional 
application No. 2019901675 filed May. 22, 2019 Customer Ref No 
DRRS/PP/02 and hereby incorporated by reference.  
HISTORICAL VIEW 
Nearly all present multi wheels ground transporter from 2 wheels (on tandem) 
up, have fix centre of gravity, when they are on the move, fairly stable on the 
straight, but not so when they are turning or on uneven ground, because of 
centrifugal force and changing ground camber, become unstable, dangerous and 
worse with increasing speed 
In transporters with 2 wheels in tandem, to offset centrifugal force and changes 
of camber gradient they actively lean into the turn to retain its stability 
With tires ground contact area constantly changes, tires profile have to be 
rounded, reducing tires ground contact area 
With smaller area of contact, significantly reduce its road holding especially 
when cornering (Fig 3a,b) 
Multi wheelers transporter when turning, they lean out because of centrifugal 
force putting more load on outside wheels and become unstable (Figlb,c) 
The instability worsened with speed, on turning, smaller turning radius, high 
transporter centre of gravity, narrow tracts and something beyond our control 
like wind direction and speed, camber of the road 
To improve stability transporter manufacturer, lowered its centre of gravity, by 
installing heavier part lower on chassis, widening its tract, fit wider tyres, 
complicated suspensions and increase body rigidity to minimise lateral flexion
Patent AU-2020204457-A1 (AU)
Title: Compositions and methods for modulating il-10 immunostimulatory and anti-inflammatory properties
Inventor: LOSEY HEATHER C
IPC: C07K14/54
Filed: 2020-07-03
Abstract: The invention provides compositions and methods for modulating the immunostimulatory 
properties and/or anti-inflammatory properties of IL-10. The present invention provides scIL
10 polypeptides of Formula 1. The polypeptides of the invention are optionally linked to a 
fusion partner.
Patent AU-2020204611-A1 (AU)
Title: Customized and assembled pool
Inventor: MEYER CHRISTOPHER
IPC: E04H4/04
Filed: 2020-07-09
Abstract: [0077] Described herein is a pool assembly and methods of manufacturing and/or installing the 
pool assembly thereby providing for an above ground pool that may be personally customized by 
a user. The pool assembly may include a pool shell, a support structure, including a base member 
and support members, and a filtration system. A user may customize, or design, the pool assembly, 
including shape, size, and dimensions, such that the pool assembly may be delivered in a plumbed 
and ready to fill state. Upon delivery, the pool need only be positioned on a flat, or level, surface, 
coupled to an energy source and filled with water, thereby eliminating the need for additional 
assembly or skilled labor.  
24 
US2008 16850860 1
101 
16 
12 
FIG. 2 
10
Patent AU-2020216056-A1 (AU)
Title: Method for preparing inhibited starch
Inventor: BRYNOLF MIKAEL
IPC: C08B30/00
Filed: 2020-01-31
Abstract: A method for preparing an inhibited starch, wherein it comprises the steps of a) providing a slurry containing a granular starch obtained from a starch containing raw material, b) alkalizing the slurry by adding ammonia or by adding one or more compounds having the ability to release or produce ammonia in the slurry, c) adjusting the p H of the slurry to a value above 10.0, preferably up to 12.0, and d) adding at least one oxidant to the slurry for a reaction with said ammonia; or wherein steps b) and c) are replaced with the step of alkalizing the slurry directly to a p H between 0.0 and 12.0, and the step of adding chloramine or dichloramine to the slurry, and wherein step d) is omitted; or wherein step c) is replaced with the step of adjusting the p H of the slurry to a value of between 7.0 and 10.0, and wherein step d) is followed by a step of adjusting the p H of the slurry to a value above 10.0, preferably up to 12.0, is disclosed, as well as an inhibited starch made with said method, use of the inhibited starch as an 1 ingredient in a food product, and a food product containing said inhibited starch.
Patent AU-2020233628-A1 (AU)
Title: Corrugated board and a process
Inventor: ROCHFORD MICHAEL
IPC: B32B37/14
Filed: 2020-09-14
Abstract: The present disclosure relates to a corrugated board and a process for manufacturing 
corrugated board. The corrugated board may including a corrugated medium, an inner 
5 layer applied to the corrugated medium, the inner layer having a metallised 
appearance; and an outer polymeric layer through which light can pass, the outer 
polymeric layer being joined to the inner layer to allow the metallized appearance of 
the inner layer to be seen through the outer polymeric layer. The corrugated board 
may also include a liner sheet that on one side is attached to crests of the corrugated 
10 board, and the inner layer having a metallised appearance may be applied to the other 
side of the liner sheet. (Figure 1) 
16570206_1 (GHMatters) P97621.AU.2 14/09/20
161 
t 7
Patent AU-2020256253-A1 (AU)
Title: ENPP1 polypeptides and methods of using same
Inventor: STABACH PAUL
IPC: C12N15/85
Filed: 2020-04-03
Abstract: The present disclosure includes ENPP1 mutant polypeptides with improved in vivo half-lives.
Patent AU-2020265828-A1 (AU)
Title: Substituted pyrrolopyridines as JAK inhibitors
Inventor: JACOBSEN ERIC JON
IPC: C07D471/04
Filed: 2020-05-04
Abstract: The present invention relates to new pyrrolopyridine compounds having the structures of Formula (I)-(IV), wherein the R groups, A, B, C, D and n are as defined in the detailed description, and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.
Patent AU-2020267191-A1 (AU)
Title: Polymeric bile acid nanocompositions targeting the pancreas and colon
Inventor: FAHMY TAREK M
IPC: A61K9/00
Filed: 2020-11-10
Abstract: Pharmaceutical composition containing poly(bile) acid (PBA) polymers for oral delivery 
of agent(s) show enhanced uptake by the pancreas, liver, and colon. These nanoparticles 
show significant retention in the pancreas and colon and are therefore useful for selective 
delivery. The examples demonstrate efficacy of oral administration of insulin to treat 
diabetes, and oral induction of tolerance by administration of insulin or ovalbumin in 
combination with rapamycin. Diabetic animals treated with the insulin or insulin with 
rapamycin showed normalization of blood glucose levels.
Patent AU-2020271133-A1 (AU)
Title: Implantable polymer depots for the controlled, sustained release of therapeutic agents
Inventor: NAGA KARUN D
IPC: A61K9/70
Filed: 2020-04-11
Abstract: The present technology relates to depots for the treatment of select symptoms via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising the therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for an extended period of time.
Patent AU-2020277088-A1 (AU)
Title: Nuclear transport modulators and uses thereof
Inventor: BALOGLU ERKAN
IPC: C07D249/08
Filed: 2020-11-23
Abstract: NUCLEAR TRANSPORT MODULATORS AND USES THEREOF 
Abstract 
Ra 
(R 1)n N Rb 
-y k -ZLX R I) 
The present invention relates to compounds of formula (I): and 
pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the 
compounds of formula (I) or their pharmaceutically acceptable salts, and methods of 
using said compounds, salts and compositions in the treatment of various disorders 
associated with CRMI activity.
Patent AU-2020278444-A1 (AU)
Title: A rubber-based aerogel
Inventor: DUONG HAI MINH
IPC: C08J9/35
Filed: 2020-05-15
Abstract: There is provided a rubber-based aerogel comprising a porous network of cross-linked rubber fibres, wherein the rubber-based aerogel has a thermal conductivity of 0.030-0.050 W/m K. There is also provided a method of forming the rubber-based aerogel.
Patent AU-2020279478-A1 (AU)
Title: Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer
Inventor: SESSLER JONATHAN L
IPC: C07F1/12
Filed: 2020-05-22
Abstract: The present disclosure relates to functionalized gold carbene naphthoquinone compounds and salts thereof. In some aspects, these compounds can be used to treat cancer including cancers which are resistant to one or more other chemotherapeutic agents such as cisplatin or platinum chemotherapeutic agents. Also provided herein are pharmaceutical compositions comprising the gold carbene naphthoquinone compounds. The present disclosure also provides methods of preparing a cancer vaccine.
Patent AU-2020296121-A1 (AU)
Title: Treatment of autism spectrum disorder and associated neuroinflammation using fibroblasts and derivatives thereof
Inventor: ICHIM THOMAS
IPC: A61K35/30
Filed: 2020-06-22
Abstract: Disclosed are means, methods, and compositions of matter useful for treatment of pervasive developmental disorders. The treatment includes the use of fibroblasts, modified fibroblasts, and derivatives thereof for reduction of neuroinflammation and/or gastrointestinal inflammation in a patient in need of treatment, such as having a pervasive developmental disorder. Fibroblasts, modified fibroblasts, and derivatives thereof may be administered at a frequency and concentration sufficient to reduce interleukin-17 production in the gut of patients with autism spectrum disorder.